AnteoTech Limited (ADO.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 221.85 Thousand AUD | 0.0% |
| 2023 | - AUD | 0.0% |
| 2022 | - AUD | -100.0% |
| 2021 | 1.00 AUD | 0.0% |
| 2020 | 1.00 AUD | 0.0% |
| 2019 | 1.00 AUD | 0.0% |
| 2018 | 1.00 AUD | 0.0% |
| 2017 | - AUD | -100.0% |
| 2016 | 5.06 Million AUD | 506981300.0% |
| 2015 | 1.00 AUD | 0.0% |
| 2014 | 1.00 AUD | 0.0% |
| 2013 | - AUD | -100.0% |
| 2012 | 2129.00 AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 100.0% |
| 2006 | -127.69 Thousand AUD | -154.2% |
| 2005 | 235.57 Thousand AUD | -83.67% |
| 2004 | 1.44 Million AUD | 38.24% |
| 2003 | 1.04 Million AUD | 34.3% |
| 2002 | 777 Thousand AUD | 18.45% |
| 2001 | 656 Thousand AUD | 270.62% |
| 2000 | 177 Thousand AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.00 AUD | 0.0% |
| 2024 FY | - AUD | 0.0% |
| 2024 Q4 | 221.85 Thousand AUD | 0.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 FY | - AUD | 0.0% |
| 2022 FY | - AUD | -100.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 Q2 | 1.00 AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 FY | 1.00 AUD | 0.0% |
| 2021 Q4 | 1.00 AUD | 0.0% |
| 2020 FY | 1.00 AUD | 0.0% |
| 2020 Q2 | 1.00 AUD | 0.0% |
| 2020 Q4 | 1.00 AUD | 0.0% |
| 2019 Q2 | 1.00 AUD | 0.0% |
| 2019 Q4 | 1.00 AUD | 0.0% |
| 2019 FY | 1.00 AUD | 0.0% |
| 2018 Q2 | 1.00 AUD | 0.0% |
| 2018 FY | 1.00 AUD | 0.0% |
| 2018 Q4 | 1.00 AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | 5.05 Million AUD | 0.0% |
| 2017 FY | - AUD | -100.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | 5.06 Million AUD | 506981300.0% |
| 2016 Q4 | 5.06 Million AUD | 0.0% |
| 2015 FY | 1.00 AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q4 | 1.00 AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 FY | 1.00 AUD | 0.0% |
| 2014 Q4 | 1.00 AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q1 | - AUD | -100.0% |
| 2013 FY | - AUD | -100.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 FY | 2129.00 AUD | 0.0% |
| 2012 Q4 | 2129.00 AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 100.0% |
| 2006 FY | -127.69 Thousand AUD | -154.2% |
| 2006 Q4 | 5750.00 AUD | 0.0% |
| 2005 Q4 | 235.57 Thousand AUD | 0.0% |
| 2005 FY | 235.57 Thousand AUD | -83.67% |
| 2004 Q4 | 1.44 Million AUD | 0.0% |
| 2004 FY | 1.44 Million AUD | 38.24% |
| 2003 FY | 1.04 Million AUD | 34.3% |
| 2003 Q4 | 1.04 Million AUD | 0.0% |
| 2002 FY | 777 Thousand AUD | 18.45% |
| 2002 Q4 | 776.88 Thousand AUD | 0.0% |
| 2001 Q4 | 655.64 Thousand AUD | 0.0% |
| 2001 FY | 656 Thousand AUD | 270.62% |
| 2000 FY | 177 Thousand AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | 113.21% |
| Acrux Limited | 147 Thousand AUD | -50.923% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -103.858% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 133.059% |
| Alterity Therapeutics Limited | 1.00 AUD | -22185600.0% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -128.443% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Biome Australia Limited | 1.88 Million AUD | 88.253% |
| Biotron Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 81.655% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 8.93 Billion AUD | 99.998% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 97.912% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -105.036% |
| Dimerix Limited | - AUD | -Infinity% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 84.167% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 125.29% |
| Immuron Limited | 1.58 Million AUD | 85.999% |
| Immutep Limited | 2.00 AUD | -11092750.0% |
| Imugene Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 333.575% |
| Memphasys Limited | 164.76 Thousand AUD | -34.654% |
| Nanollose Limited | - AUD | -Infinity% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 109.404% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | 81.145% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 101.233% |
| Race Oncology Limited | 16.4 Thousand AUD | -1252.704% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 122.469% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Starpharma Holdings Limited | 2.4 Million AUD | 90.787% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 98.718% |
| Tissue Repair Ltd | 214.72 Thousand AUD | -3.323% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 82.284% |